PRISMA harms checklist: improving harms reporting in systematic reviews
BMJPublished 1 February 2016Open access
Liliane Zorzela, Yoon K. Loke, John P. A. Ioannidis, Su Golder, Pasqualina Santaguida, Douglas G. Altman
Citations522
SJR quartileQ1
SJR score2.98
SNIP9.45
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveWill appear once the snapshot is generated
MethodsWill appear once the snapshot is generated
PopulationWill appear once the snapshot is generated
Sample sizeWill appear once the snapshot is generated
OutcomesWill appear once the snapshot is generated
ResultsWill appear once the snapshot is generated
LimitationsWill appear once the snapshot is generated
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The PRISMA harms checklist identifies a minimal set of items to be reported when reviewing adverse events, intended to improve harms reporting in systematic reviews, whether harms are a primary or secondary outcome.
Abstract
The PRISMA harms checklist identifies a minimal set of items to be reported when reviewing adverse events. This guideline extension is intended to improve harms reporting in systematic reviews, whether harms are a primary or secondary outcome.
Keywords
Decision SciencesMathematicsEconomics, Econometrics and Finance
DergiPark (Istanbul University)Yaşlı Kadınlarda Üreme Sağlığı
169,601 CitationsKokanalı, Demet, Engin Üstün, Yaprak
PLoS MedicinePreferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
64,081 Citations2009David Moher, Alessandro Liberati +3 more
Higher quality, large, multicenter RCTs are needed to demonstrate the preventive effect of the two acid-suppressive drugs, PPIs were superior to H2RAs for prevention of LDA-related GI erosion/ulcer and bleeding.
Cochrane Handbook for Systematic Reviews of Interventions
24,936 Citations2008
JAMAMeta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
20,682 Citations2000Donna F. Stroup
A checklist contains specifications for reporting of meta-analyses of observational studies in epidemiology, including background, search strategy, methods, results, discussion, and conclusion should improve the usefulness ofMeta-an analyses for authors, reviewers, editors, readers, and decision makers.
BMJPreferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
13,175 Citations2015Larissa Shamseer, David Moher +7 more
Research Explorer (The University of Manchester)Correspondence - Tranexamic acid for traumatic brain injury
11,773 Citations2005Reynard, Charles; id_orcid 0000-0002-7534-2668, Berg, Patricia van den +1 more
The CLOTS 3 trial evaluated the effectiveness of intermittent pneumatic compression in immobile patients with acute stroke to reduce the risk of venous thromboembolism and possibly improving survival in a wide variety of patients who are immobile after stroke.
BMJRecommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials
7,394 Citations2011Jonathan A C Sterne, Alex J. Sutton +17 more
How to interpret funnel plot asymmetry, recommends appropriate tests, and explains the implications for choice of meta-analysis model are described.
Journal of the Royal Society of MedicineThe environment and disease: association or causation?
7,311 Citations2015Austin Bradford Hill
The objects of this newly founded Section of Occupational Medicine are to provide a means, not readily afforded elsewhere, whereby physicians and surgeons with a special knowledge of the relationship between sickness and injury and conditions of work may discuss their problems, not only with each other, but also with colleagues in other fields, by holding joint meetings with other Sections of the Society.
Proceedings of the Royal Society of MedicineThe Environment and Disease: Association or Causation?
6,888 Citations1965Austin Bradford Hill
This paper contrasts Bradford Hill’s approach with a currently fashionable framework for reasoning about statistical associations – the Common Task Framework – and suggests why following Bradford Hill, 50+ years on, is still extraordinarily reasonable.
JAMAEmpirical Evidence for Selective Reporting of Outcomes in Randomized Trials
1,806 Citations2004An‐Wen Chan, Asbjørn Hróbjartsson +3 more
The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.
Health Technology AssessmentConsensus development methods, and their use in clinical guideline development.
1,795 Citations1998Murphy Murphy, Jed Black +5 more
This assessment aims to identify the factors that affect the decisions that emerge from consensus development methods and to assess the implications of the findings for the development of clinical guidelines.
BMJThe case of the misleading funnel plot
1,758 Citations2006Joseph Lau, John P. A. Ioannidis +3 more
Evidence based medicine insists on rigorous standards to appraise clinical interventions, and failure to apply the same rules to its own tools could be equally damaging.
Statistics in MedicineWhat to add to nothing? Use and avoidance of continuity corrections in meta‐analysis of sparse data
1,706 Citations2004Michael Sweeting, Alex J. Sutton +1 more
Many routinely used summary methods provide widely ranging estimates when applied to sparse data with high imbalance between the size of the studies' arms, including Mantel-Haenszel summary estimates using the alternative continuity correction factors, which gave the least biased results for all group size imbalances.
Annals of Internal MedicineBetter Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
1,522 Citations2004John P. A. Ioannidis, Stephen J.W. Evans +6 more
This work searched MEDLINE, EMBASE, Web of Science, and the Cochrane Library using a wide array of terms related to harms and identified pertinent evidence and made recommendations on the appropriate reporting of harms in RCTs.
PLoS MedicineGuidance for Developers of Health Research Reporting Guidelines
1,380 Citations2010David Moher, Kenneth F. Schulz +2 more
David Moher and colleagues from the EQUATOR network offer guidance and recommended steps for developing health research reporting guidelines.
The LancetReducing waste from incomplete or unusable reports of biomedical research
1,359 Citations2014Paul Glasziou, Douglas G. Altman +7 more
The high amount of waste at all stages in medical research warrants future investment in the monitoring of and research into reporting of research, and active implementation of the findings to ensure that research reports better address the needs of the range of research users.
BMJThe impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews
1,114 Citations2010Jamie J Kirkham, Kerry Dwan +5 more
Outcome reporting bias is an under-recognised problem that affects the conclusions in a substantial proportion of Cochrane reviews and individuals conducting systematic reviews need to address explicitly the issue of missing outcome data for their review to be considered a reliable source of evidence.
Statistics in MedicineMuch ado about nothing: a comparison of the performance of meta‐analytical methods with rare events
941 Citations2006Michael J. Bradburn, Jonathan J Deeks +2 more
At event rates below 1 per cent the Peto one‐step odds ratio method was the least biased and most powerful method, and provided the best confidence interval coverage, provided there was no substantial imbalance between treatment and control group sizes within trials, and treatment effects were not exceptionally large.
e-publications@bond (Bond University)Biomedical research: Increasing value, reducing waste
797 Citations2014Macleod, Malcolm, Michie, Susan +7 more
The Journal of Clinical Endocrinology & MetabolismAdverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
711 Citations2010Mercè Fernández-Balsells, M. Hassan Murad +11 more
The adverse effects of testosterone therapy include an increase in hemoglobin and hematocrit and a small decrease in high-density lipoprotein cholesterol.
PLoS MedicinePRISMA for Abstracts: Reporting Systematic Reviews in Journal and Conference Abstracts
690 Citations2013Elaine Beller, Paul Glasziou +8 more
Elaine Beller and colleagues from the PRISMA for Abstracts group provide a reporting guidelines for reporting abstracts of systematic reviews in journals and at conferences.
BMJPerinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis
688 Citations2008Marc Arbyn, Maria Kyrgiou +6 more
In the treatment of cervical intraepithelial neoplasia, cold knife conisation and probably both laser conisations and radical diathermy are associated with an increased risk of subsequent perinatal mortality and other serious pregnancy outcomes, unlike laser ablation and cryotherapy.
Statistics in MedicineRandom effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data
663 Citations2010Theo Stijnen, Taye H. Hamza +1 more
It is shown that problems can be overcome in most cases occurring in practice by replacing the approximate normal within-study likelihood by the appropriate exact likelihood, which leads to a generalized linear mixed model that can be fitted in standard statistical software.
Systematic ReviewsDoes use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane reviewa
629 Citations2012Lucy Turner, Larissa Shamseer +3 more
It is suggested that journal endorsement of CONSORT may benefit the completeness of reporting of RCTs they publish, and between endorsing and non-endorsing journals, 25 outcomes are improved with CONSORT endorsement, five of these significantly.
Journal of Vascular SurgeryEvidence-based healthcare: how to make health policy and management decisions
610 Citations1999Chambers, L. W.
This book explains how evidence based decision making can be applied to health policy and management decisions about groups of patients and populations, rather than decisions about the treatment of individuals.
PubMedCompleteness of safety reporting in randomized trials: an evaluation of 7 medical areas.
568 Citations2001John P. A. Ioannidis, Joseph Lau
Current standards for safety reporting in randomized trials should be revised to address this inadequacy, as generalizable data on drug safety reporting are sparse and largely inadequate.
BMJPRISMA harms checklist: improving harms reporting in systematic reviews
522 Citations2016Liliane Zorzela, Yoon K. Loke +7 more
The PRISMA harms checklist identifies a minimal set of items to be reported when reviewing adverse events, intended to improve harms reporting in systematic reviews, whether harms are a primary or secondary outcome.
The LancetIncreasing value and reducing waste in biomedical research: who's listening?
458 Citations2015David Moher, Paul Glasziou +7 more
This Review provides some initial observations on the possible effects of the series of five reviews of how dividends from the investment in research might be increased, which seems to have provoked several important discussions and is on the agendas of several key players.
BMJReasons or excuses for avoiding meta-analysis in forest plots
449 Citations2008John P. A. Ioannidis, Nikolaos A. Patsopoulos +1 more
John Ioannidis, Nikolaos Patsopoulos, and Hannah Rothstein show that final synthesis is possible and desirable in most cases.
Canadian Medical Association JournalOutcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research
446 Citations2004A.-W. Chan
Whether outcome reporting bias would be present in a cohort of government-funded trials subjected to rigorous peer review and whether primary outcomes specified in trial protocols were compared with those reported in publications is compared.
BMJChoosing the best research design for each question
374 Citations1997David L. Sackett, John E. Wennberg
Annals of the Rheumatic DiseasesThe safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events
359 Citations2008John Paul Leombruno, TR Einarson +1 more
Evaluating the safety of biological treatments for rheumatoid arthritis (RA) using results from randomised controlled trials (RCT) found no increase in the odds of death, and meta-regression identified that the risk of serious infection with anti-TNF therapy decreases with increasing trial duration.
Cochrane Database of Systematic ReviewsBias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions
280 Citations2014Matthew J. Page, Joanne E. McKenzie +5 more
The characteristics and synthesise the results of empirical studies that have investigated the prevalence and factors associated with selective inclusion or reporting in systematic reviews of randomised controlled trials (RCTs) of healthcare interventions are summarized.
Archives of Internal MedicineReporting of Safety Results in Published Reports of Randomized Controlled Trials
278 Citations2009Isabelle Pitrou, Isabelle Boutron +2 more
Important heterogeneity and variability in the reporting of harm-related results in publications of RCTs is revealed, especially when results are statistically significant.
Statistics in MedicineWhy add anything to nothing? The arcsine difference as a measure of treatment effect in meta‐analysis with zero cells
257 Citations2008Gerta Rücker, Guido Schwarzer +2 more
For clinical trials with binary endpoints there are a variety of effect measures, for example risk difference, risk ratio and odds ratio, which should reflect the clinical question.
BMC Medical Research MethodologySystematic reviews of adverse effects: framework for a structured approach
251 Citations2007Yoon K. Loke, Deirdre Price +2 more
This discussion paper was developed by consensus among experienced reviewers, members of the Adverse Effects Subgroup of The Cochrane Collaboration, and supplemented by a consultation of content experts in reviews methodology, as well as those working in drug safety.
BMJComparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
243 Citations2011Yoon K. Loke, Chun Shing Kwok +1 more
Among patients with type 2 diabetes, use of rosig litazone is associated with significantly higher odds of congestive heart failure, myocardial infarction, and death relative to pioglitazone in real world settings.
BMJQuality of reporting in systematic reviews of adverse events: systematic review
230 Citations2014Liliane Zorzela, Su Golder +6 more
Systematic reviews compound the poor reporting of harms data in primary studies by failing to report on harms or doing so inadequately, and the need for a reporting guideline specific for reviews of harms is determined.
Archives of Internal MedicineAdverse Events in Randomized Trials
228 Citations2009John P. A. Ioannidis
An excellent study by Pitrou et al adds more evidence on harms of interventions to the literature and shows that many trials do not report harms or report them in a fragmented or suboptimal way.
BMJMortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
227 Citations2011Sonal Singh, Y. K. Loke +2 more
This meta-analysis explains safety concerns by regulatory agencies and indicates a 52% increased risk of mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease.
TrialsDrug safety assessment in clinical trials: methodological challenges and opportunities
216 Citations2012Sonal Singh, Yoon K. Loke
The principal methodological challenges in the reporting, analysis and interpretation of safety data in clinical trials are summarized using recent examples from systematic reviews and potential solutions are discussed.
BMJSelective reporting bias of harm outcomes within studies: findings from a cohort of systematic reviews
212 Citations2014Pooja Saini, Y. K. Loke +4 more
The number of reviews suspected of outcome reporting bias as a result of missing or partially reported harm related outcomes from at least one eligible study is high and the declaration of important harms and the quality of the reporting of harm outcomes must be improved in both primary studies and systematic reviews.
Journal of Clinical EpidemiologyAHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program
182 Citations2008Roger Chou, Naomi Aronson +7 more
Advice for evaluating harms when conducting and reportingComparative effectiveness reviews is presented, including suggestions for prioritizing harms to be evaluated, use of terminology related to reporting of harms, selection of sources of evidence on harms, and assessment of risk of bias (quality) of harms reporting.
PLoS ONEMetamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis
164 Citations2015Thomas Kötter, Bruno R. da Costa +6 more
For short-term use in the hospital setting, metamizole seems to be a safe choice when compared to other widely used analgesics, but high-quality, adequately sized trials assessing the intermediate- and long-term safety of metamzole are needed.
Journal of Hospital MedicineThe FDA extended warning for intravenous haloperidol and torsades de pointes: How should institutions respond?
156 Citations2010Carla Meyer‐Massetti, Christine M. Cheng +3 more
It is suggested that a total cumulative dose of IV haloperidol of <2 mg can safely be administered without ongoing electrocardiographic monitoring in patients without concomitant risk factors.
Annals of Internal MedicineChallenges in Systematic Reviews That Assess Treatment Harms
147 Citations2005Roger Chou, Mark Helfand
BMJAngiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials
135 Citations2011Sripal Bangalore, Sunil Kumar +2 more
This large and comprehensive analysis produced firm evidence to refute the hypothesis that angiotensin receptor blockers increase the risk of myocardial infarction (ruling out even a 0.3% absolute increase).
BMC Clinical PharmacologyReporting of adverse drug reactions in randomised controlled trials – a systematic survey
129 Citations2001Yoon K. Loke, Sheena Derry
Statistics in MedicineEmpirical vs natural weighting in random effects meta‐analysis
123 Citations2009Jonathan J. Shuster
It is recommended that empirically based weighted random effects meta-analysis not be used in the future, unless strong cautions about the assumptions underlying these analyses are stated, and at a minimum, some form of secondary analysis based on the principles set forth in this article be provided to supplement the primary analysis.
Drug SafetyBisphosphonates and Atrial Fibrillation
122 Citations2009Yoon K. Loke, Vinodh Jeevanantham +1 more
Heterogeneity of the existing evidence, as well as paucity of information on some of the agents, precludes any definitive conclusions on the exact nature of the risk of atrial fibrillation associated with bisphosphonate use.
Diabetes Obesity and MetabolismBi‐directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucose‐lowering agents: a systematic review and meta‐analysis
122 Citations2015Katharina Mattishent, Y. K. Loke
To examine the bi‐directional relationship, whereby hypoglycaemia is a risk factor for dementia, and where dementia increases risk of hyp glucosecaemia in older patients with diabetes mellitus treated with glucose‐lowering agents, a study of patients with Diabetes mellitus with and without dementia is conducted.
New England Journal of MedicineThe Safety of Tiotropium — The FDA's Conclusions
113 Citations2010Theresa M. Michele, Simone Pinheiro +1 more
Tiotropium delivered by the HandiHaler device, the first long-acting anticholinergic bronchodilator for treatment of COPD, reduces COPD exacerbations and concerns have been raised about tiotropia's safety.
BMC Medical Research MethodologyIncomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
111 Citations2001Sheena Derry, Yoon K. Loke +1 more
Specific search strategies based on adverse effects textwords and indexing terms will fail to identify nearly a quarter of trials that report on the rate of drug adverse effects.
Statistics in MedicineFixed <i>vs</i> random effects meta‐analysis in rare event studies: The Rosiglitazone link with myocardial infarction and cardiac death
107 Citations2007Jonathan J. Shuster, Lynn S. Jones +1 more
It will be demonstrated that a common practice of testing for homogeneity of effect size, and acting upon the inference to decide between fixed vs random effects, can lead to potentially misleading results.
Journal of Clinical OncologyAdverse Event Reporting in Publications Compared With Sponsor Database for Cancer Clinical Trials
106 Citations2006Orit Scharf, A. Dimitrios Colevas
Lack of consistency in and reporting of AEs are associated with NCI database and trial publication AE data discrepancy.
Journal of Clinical EpidemiologyPoor reporting and inadequate searches were apparent in systematic reviews of adverse effects
103 Citations2008Su Golder, Yoon K. Loke +1 more
This investigation shows the variation in the searching element of systematic reviews of adverse effects and demonstrates that the reporting of the methods used to identify research in such reviews could be vastly improved.
Drug SafetyLong-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs
102 Citations2009Ryan Banach, Radinka Boskovic +2 more
Although the analysis revealed no evidence that untreated maternal epilepsy was associated with a lower IQ in the child, there may have been confounding factors, such as milder epilepsy, in this group.
Drug SafetySerenoa repens (Saw Palmetto)
96 Citations2009Taofikat B. Agbabiaka, Max H Pittler +2 more
Currently available data suggest that S. repens is well tolerated by most users and is not associated with serious adverse events, but higher quality reporting of adverse events is essential if safety assessments are to be improved in future.
BMJAssessment of therapeutic safety in systematic reviews: literature review
94 Citations2001E. Ernst, M.H. Pittler
Clinical RehabilitationSafety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials
93 Citations2009Cidronio Albavera-Hernández, J. Martín Rodríguez +1 more
Botulinum toxin type A has a good safety profile during the first months of use, however the occurrence of adverse events is more frequent among children with cerebral palsy than individuals with other conditions, and additional study is required to clarify the causal relation.
The American Journal of GastroenterologyRobustness Assessments Are Needed to Reduce Bias in Meta-Analyses That Include Zero-Event Randomized Trials
90 Citations2009Frederik Keus, Jørn Wetterslev +3 more
The statistical method may influence the inference drawn from a meta-analysis that includes zero-event trials, and robustness assessments are needed to reduce bias in meta-analyses that include zero- event trials.
BMC Pregnancy and ChildbirthMaternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
77 Citations2013Emily Bain, Philippa Middleton +1 more
Appropriate administration of antenatal magnesium sulphate was not shown to be associated with serious maternal adverse effects, Though an increase in 'minor’ adverse effects and treatment cessation was shown, and adverse effect estimates from studies of other designs largely supported data from randomised trials.
Annals of Emergency MedicineThe Effect of a Bolus Dose of Etomidate on Cortisol Levels, Mortality, and Health Services Utilization: A Systematic Review
75 Citations2010Corinne M. Hohl, Carolyn H. Kelly-Smith +4 more
The available evidence suggests that etomidate suppresses adrenal function transiently without demonstrating a significant effect on mortality, and no studies to date have been powered to detect a difference in hospital, ventilator, or ICU length of stay or in mortality.
The American Journal of MedicineAvailability of large-scale evidence on specific harms from systematic reviews of randomized trials
75 Citations2004Panagiotis N. Papanikolaou, John P. A. Ioannidis
To assess how frequently systematic reviews of randomized controlled trials convey large-scale evidence on specific, well-defined adverse events, the Cochrane Database of Systematic Reviews was searched.
BMC Medical Research MethodologyRoom for improvement? A survey of the methods used in systematic reviews of adverse effects
74 Citations2006Su Golder, Yoon K. Loke +1 more
Where methodological research is most needed to improve systematic reviews of adverse effects of health care interventions, a descriptive analysis of systematic reviews published between 1994 and 2005 found the methodology around identification and quality assessment of primary data is the main concern.
BMC Medical Research MethodologyAssessing harmful effects in systematic Reviews
70 Citations2004Heather M McIntosh, Nerys Woolacott +1 more
Journal of Clinical EpidemiologyReporting of adverse events in systematic reviews can be improved: survey results
68 Citations2008Sally Hopewell, Luke Wolfenden +1 more
Most Cochrane reviews of drug interventions considered adverse events, but this was not the case for DARE reviews and for Cochrane Reviews of nondrug interventions.
Pharmacoepidemiology and Drug SafetySystematic reviews of adverse effects of drug interventions: a survey of their conduct and reporting quality
58 Citations2009Victoria Cornelius, Michael Perrio +2 more
Assessment of the current methods and reporting used by systematic reviews of the adverse effects of medical interventions to inform policy, practice and research.
British Journal of AnaesthesiaDexamethasone and haemorrhage risk in paediatric tonsillectomy: a systematic review and meta-analysis
56 Citations2014Jennifer R Bellis, Munir Pirmohamed +5 more
The pooled analysis did not demonstrate a statistically significant increase in the risk of post-tonsillectomy haemorrhage with dexamethasone with/without NSAID use in children, and thus large studies which are specifically designed to collect data on haem orrhage rate are needed.
PubMedClarifying the abstracts of systematic literature reviews.
50 Citations2000James Hartley
The abstracts of systematic reviews should be easier to read than the Abstracts of medical research articles, as they are targeted at a wider audience and need to be presented in a consistent way to help search and retrieval.
Therapeutic Advances in Drug SafetyComprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources
49 Citations2011Yoon K. Loke, Su Golder +1 more
Critical CareA systematic review of adult admissions to ICUs related to adverse drug events
38 Citations2014Pierre-Alain Jolivot, Patrick Hindlet +5 more
It is indicated that ICU admission due to ADE is a significant issue that should deserve further interest and a list of items devoted to the reporting of future studies on ADE requiring ICU admissions is proposed.
American Heart JournalChallenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
38 Citations2008Adrían V. Hernández, Esteban Walker +2 more
The methods used in previous published meta-analyses for harmful cardiovascular events, with special attention to the rosiglitazone meta-analysis, are examined, and suggestions for the improvement of methods and interpretation are given.
Journal of Clinical EpidemiologySome improvements are apparent in identifying adverse effects in systematic reviews from 1994 to 2011
34 Citations2013Su Golder, Yoon K. Loke +1 more
Some improvements in searching systematic reviews of adverse effects are apparent; however, poor reporting of search strategies remains a great obstacle to readers.
Journal of Clinical EpidemiologyUnpublished data can be of value in systematic reviews of adverse effects: methodological overview
32 Citations2010Su Golder, Yoon K. Loke +1 more
There is insufficient evidence to indicate whether inclusion of unpublished studies has a major influence on the pooled risk estimates in meta-analyses of adverse effects, but inclusion of published studies can provide additional adverse effects information and more precise risk estimates.
Journal of Clinical EpidemiologyMethodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions
31 Citations2006Roger Chou, Rongwei Fu +3 more
Clinicians and researchers should consider methodological shortcomings when evaluating estimates of harms associated with clinical interventions, as the presence of methodological shortcomings can predict lower estimates of serious harms.
Complementary Therapies in MedicineComplementary medicine and safety: A systematic investigation of design and reporting of systematic reviews
31 Citations2011Karen Pilkington, Anelia Boshnakova
Detailed examination and comparison of the methods has highlighted several areas in which there is potential for development of guidelines and consensus on standards, including search strategies, sources of information, data extraction and assessment of causality.
Cochrane Database of Systematic ReviewsBias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions
31 Citations2012Matthew J. Page, Joanne E. McKenzie +4 more
Journal of Clinical EpidemiologyOptimal type I and type II error pairs when the available sample size is fixed
29 Citations2013John P. A. Ioannidis, Iztok Hozo +1 more
The proposed optimization equations can be used to guide the selection of the optimal type I and type II errors of future studies in which sample size is constrained.
PEDIATRICSSafety of Medical Interventions in Children Versus Adults
28 Citations2014Dimitrios Lathyris, Orestis A. Panagiotou +3 more
PubMedSome concerns about adverse event reporting in randomized clinical trials.
26 Citations2008Yusuf Yazıcı
This article focuses on some of the shortcomings of AE reporting in RCTs, especially those involving tumor necrosis factor (TNF) inhibitors, and focuses on reporting of "time-to-event" issues, use of standardized incidence ratios for comparison to normal population or disease controls, and the problem of adequate sample size and power calculations that are lacking in safety outcome data trials.
International Journal of Technology Assessment in Health CareTHE CONTRIBUTION OF DIFFERENT INFORMATION SOURCES FOR ADVERSE EFFECTS DATA
22 Citations2012Su Golder, Yoon K. Loke
The relative value and contribution of searching different sources to identify adverse effects data is determined and the minimum combination of sources required to identify all the relevant references did not include MEDLINE.
Clinical TrialsReporting of meta-analyses of randomized controlled trials with a focus on drug safety: An empirical assessment
22 Citations2013Tarek A. Hammad, George A. Neyarapally +4 more
A preliminary reporting framework based on PRISMA is developed with specific additional reporting elements critical for the evaluation of drug safety meta-analyses of RCTs, highlighting the need for the development and validation of a drug safety reporting framework.
Journal of the Medical Library Association JMLAFailure or success of electronic search strategies to identify adverse effects data
16 Citations2012Su Golder, Yoon K. Loke
This study collected a large, diverse, and contemporaneous cohort of articles with adverse effects data so that the presence or absence of specific adverse effects terms could be assessed.
Canadian Medical Association JournalIf nothing happens, is everything all right? Distinguishing genuine reassurance from a false sense of security
16 Citations2014Yoon K. Loke, Katharina Mattishent
In a linked research paper, Gillies and colleagues present a systematic review and meta-analyses showing a favourable safety profile for amoxicillin.
PLoS ONEAdverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
14 Citations2013Miranda Langendam, Edine Tiemersma +2 more
Although the number of publications and quality of evidence are low, the available evidence suggests that shortly after starting treatment the occurrence of serious adverse events is rare and Mild adverse events occur more frequently and may be of importance because these may provoke treatment interruption.
Clinical Research and Regulatory AffairsDoes Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Safety and Postmarketing Surveillance
14 Citations1996Charles Anello, Robert T. O’Neill
Clinical Research and Regulatory AffairsDoes Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Efficacy and Drug Approval
9 Citations1996Robert T. O’Neill, Charles Anello
Canadian Journal of Anesthesia/Journal canadien d anesthésieImproving the reporting and usability of research studies
8 Citations2013Larissa Shamseer, James Galipeau +2 more
Several of the currently available resources to improve the reporting and usability of bio-medical research are highlighted to help improve the current state of the reported medical literature.
The LancetAdverse-event rates: journals versus databases
5 Citations2007Michelle R. Mahoney, Daniel J. Sargent
Survey of AnesthesiologyDexamethasone and Haemorrhage Risk in Paediatric Tonsillectomy
2 Citations2015Jennifer R Bellis, Munir Pirmohamed +5 more
…